1. Home
  2. CNA vs TECH Comparison

CNA vs TECH Comparison

Compare CNA & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNA Financial Corporation

CNA

CNA Financial Corporation

N/A

Current Price

$47.36

Market Cap

13.1B

Sector

Finance

ML Signal

N/A

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

N/A

Current Price

$72.78

Market Cap

11.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNA
TECH
Founded
1853
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1B
11.4B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
CNA
TECH
Price
$47.36
$72.78
Analyst Decision
Hold
Analyst Count
0
13
Target Price
N/A
★ $70.50
AVG Volume (30 Days)
378.3K
★ 2.8M
Earning Date
11-02-2026
11-17-2026
Dividend Yield
★ 3.99%
0.44%
EPS Growth
33.24
★ 152.17
EPS
★ 2.67
1.16
Revenue
★ $14,989,000,000.00
$1,215,039,000.00
Revenue This Year
$7.50
$4.38
Revenue Next Year
N/A
$10.06
P/E Ratio
★ $17.99
$62.70
Revenue Growth
★ 5.04
N/A
52 Week Low
$41.53
$43.20
52 Week High
$55.71
$72.83

Technical Indicators

Market Signals
Indicator
CNA
TECH
Relative Strength Index (RSI) 46.76 59.27
Support Level $47.09 $72.11
Resistance Level $49.45 N/A
Average True Range (ATR) 1.04 0.12
MACD -0.06 -0.00
Stochastic Oscillator 48.23 78.57

Price Performance

Historical Comparison
CNA
TECH

About CNA CNA Financial Corporation

CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance. The company operates under five segments: Specialty, Commercial and International being its core business, and two segments for its non-core businesses, which are Life and Group and Corporate and Other. CNAF, through its segments, provides professional, financial, specialty property, and casualty products to small businesses and medium-scale organizations. It has its business spread across Continental Europe, United Kingdom, and Canada. The majority of the revenues are generated from the Specialty and Commercial segment of the business.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: